Economic evaluation of dapagliflozin as add-on to metformin in type 2 diabetes in the Israeli healthcare setting

被引：0
|
作者：
Moshel, S. [1 ]
Vexberg, M. Hirsch [1 ]
Shavit, O. [1 ]
Toledano, Y. [1 ]
机构：
[1] Meuhedet Hlth Fund, Tel Aviv, Israel
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
639
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [1] ECONOMIC EVALUATION OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR T2DM TREATMENT IN THE ISRAELI HEALTHCARE SETTING
    Moshel, S.
    Vexberg, Hirsch M.
    Shavit, O.
    Toledano, Y.
    VALUE IN HEALTH, 2018, 21 : S131 - S131
  • [2] Economic Evaluation of Dapagliflozin as Add-On to Metformin in T2DM in the Israeli Health Care Setting
    Moshel, Shai
    Vexberg, Michal Hirsch
    Shavit, Oren
    Toledano, Yoel
    DIABETES, 2018, 67
  • [3] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Tzanetakos, C.
    Tentolouris, N.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A607
  • [4] DAPAGLIFLOZIN: COST EFFECTIVENESS AS AN ADD-ON THERAPY TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES IN ECUADOR
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Sanchez, Solis C.
    Acosta, W.
    Solorzano, J.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2016, 19 (03) : A202 - A202
  • [5] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [6] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    DIABETES, 2018, 67
  • [7] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [8] Add-on therapies to metformin for type 2 diabetes
    Shomali, Mansur
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) : 47 - 62
  • [9] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [10] Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece
    Charalampos Tzanetakos
    Nicholas Tentolouris
    Georgia Kourlaba
    Nikos Maniadakis
    Clinical Drug Investigation, 2016, 36 : 649 - 659
12345